MRNA · News · 20261112N

Guidance / Outlook

Moderna, Inc. · 2026-11-12 · Importance 90 · Surprise 84 · In source text

Moderna raised its 2026 revenue growth forecast to 15%–25% and expects significant gross margin expansion. It projected approximately $9 billion in total liquidity by year-end 2026. At Analyst Day, it gave a 2027 cash cost target of about $4 billion, above the midpoint of its prior guidance, but did not provide a 2027 revenue forecast. The reported increase in expected spending was particularly associated with oncology investment.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
revenuepositivecommitted+17.0%Moderna raised its 2026 revenue growth forecast to 15% to 25%.